Elanco’s 2025 Impact Report outlines the company’s progress in advancing animal health through product innovation, sustainable food production, veterinary support and community investment while reinforcing its long-term business strategy.
PetIQ has expanded its pet health and wellness portfolio through the acquisition of MYOS Corp., adding the clinically studied Fortetropin® muscle health platform. The deal positions the company to compete in the growing market for mobility, recovery, and healthy aging products for companion animals.
The Veterinary Angel Network for Entrepreneurs (VANE) has invested in PawPay, a veterinary fintech company developing a platform that enables pet insurance claims to be processed at the point of care. The investment will support PawPay’s commercial expansion as it works to simplify insurance payments for veterinary practices and insured pet owners.
Tractor Supply Company reported second-quarter 2026 net sales of $4.54 billion, up 2.3% from the prior year, while comparable store sales declined 1.5%. The retailer also lowered its full-year 2026 outlook, citing year-to-date performance, and recorded restructuring charges related to its Petsense business and acquisition costs associated with its purchase of VIP Petcare.
Nestlé reported 3.6% organic growth for the first half of 2026, driven by improving volume growth, stronger performance in emerging markets and continued investment in key brands. The company reaffirmed its full-year outlook while highlighting ongoing portfolio changes and efficiency initiatives.
Central Bark reported a record-breaking second quarter, with systemwide sales increasing 17% year over year and same-store sales rising 11%. The company says growing demand for premium pet care services helped drive its strongest quarterly performance to date across its 44-location franchise network.
IDEXX’s 2025 Corporate Responsibility Report highlights new advances in veterinary diagnostics, workforce development and sustainability initiatives. The report details progress toward the company’s long-term goals while showcasing investments designed to expand access to care, strengthen veterinary practices and support future innovation.
Virbac reported first-half 2026 revenue of €768 million, representing 7.4% organic growth at constant exchange rates and scope (CERS), driven by double-digit growth across its Supercharge platforms and balanced gains in both companion and farm animal segments. The company also reaffirmed its full-year financial guidance, citing strong momentum across North America, Europe and international markets despite currency headwinds and localized operational challenges.
CVS Health® is bringing prescription medications for dogs and cats to nearly 9,000 CVS Pharmacy® locations across the U.S., giving pet owners another option for filling common veterinary prescriptions while adding new digital tools to simplify medication management.
PetMeds has officially launched its first large-scale white-label pharmacy program through Rural King, expanding online access to prescription medications, pet food and preventive care products for pet owners, particularly in rural communities.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.